Renkai Li

812 total citations
24 papers, 596 citations indexed

About

Renkai Li is a scholar working on Molecular Biology, Pharmacology and Complementary and alternative medicine. According to data from OpenAlex, Renkai Li has authored 24 papers receiving a total of 596 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 8 papers in Pharmacology and 8 papers in Complementary and alternative medicine. Recurrent topics in Renkai Li's work include Bioactive Compounds and Antitumor Agents (4 papers), Antifungal resistance and susceptibility (4 papers) and Fungal Biology and Applications (4 papers). Renkai Li is often cited by papers focused on Bioactive Compounds and Antitumor Agents (4 papers), Antifungal resistance and susceptibility (4 papers) and Fungal Biology and Applications (4 papers). Renkai Li collaborates with scholars based in Hong Kong, China and Macao. Renkai Li's co-authors include David W. Warnock, Jingjing Li, Gph Leung, Meral A. Cıblak, Michael R. McGinnis, L Pasarell, Simon Ming‐Yuen Lee, Jinming Zhang, Chaomei Fu and Mary E. Brandt and has published in prestigious journals such as ACS Applied Materials & Interfaces, Antimicrobial Agents and Chemotherapy and Infection and Immunity.

In The Last Decade

Renkai Li

24 papers receiving 580 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Renkai Li Hong Kong 13 268 229 160 82 66 24 596
Nessim Kichik United Kingdom 13 286 1.1× 177 0.8× 248 1.6× 52 0.6× 90 1.4× 15 660
Jundong Zhang China 15 179 0.7× 124 0.5× 294 1.8× 113 1.4× 62 0.9× 37 693
Jyh‐Sheng You Taiwan 10 138 0.5× 168 0.7× 154 1.0× 44 0.5× 50 0.8× 15 472
Caio César de Souza Alves Brazil 16 131 0.5× 129 0.6× 188 1.2× 100 1.2× 43 0.7× 56 687
Lian‐Qiu Wu China 16 240 0.9× 99 0.4× 347 2.2× 73 0.9× 168 2.5× 49 895
Jongseok Lee South Korea 15 362 1.4× 346 1.5× 202 1.3× 40 0.5× 97 1.5× 30 813
Anna H.Y. Law Hong Kong 9 94 0.4× 209 0.9× 177 1.1× 56 0.7× 27 0.4× 11 508
Jinghua Yu China 16 83 0.3× 93 0.4× 374 2.3× 52 0.6× 40 0.6× 40 686

Countries citing papers authored by Renkai Li

Since Specialization
Citations

This map shows the geographic impact of Renkai Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Renkai Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Renkai Li more than expected).

Fields of papers citing papers by Renkai Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Renkai Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Renkai Li. The network helps show where Renkai Li may publish in the future.

Co-authorship network of co-authors of Renkai Li

This figure shows the co-authorship network connecting the top 25 collaborators of Renkai Li. A scholar is included among the top collaborators of Renkai Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Renkai Li. Renkai Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Mingxia, Zhikan Yao, Renkai Li, et al.. (2025). Colon-Targeted Hydrogel Microsphere System Encapsulating Oleic Acid–Emodin for Crohn’s Disease Treatment via Ferroptosis Inhibition. ACS Applied Materials & Interfaces. 17(9). 13676–13689. 1 indexed citations
2.
Chen, Mingxia, Jinlan Huang, Guihao Zhang, et al.. (2025). Analysis of Pharmacological Activities and Mechanisms of Essential Oil in Flowers of Citrus grandis ‘Tomentosa’ by GC-MS/MS and Network Pharmacology. Current Issues in Molecular Biology. 47(7). 541–541. 1 indexed citations
3.
Rangsinth, Panthakarn, Renkai Li, Tewin Tencomnao, et al.. (2024). Neuroprotective Effects of Polysaccharides and Gallic Acid from Amauroderma rugosum against 6-OHDA-Induced Toxicity in SH-SY5Y Cells. Molecules. 29(5). 953–953. 5 indexed citations
4.
Nie, Xin, Li Fu, Yanfen Cheng, et al.. (2023). Garcinone E suppresses breast cancer growth and metastasis by modulating tumor‐associated macrophages polarization via STAT6 signaling. Phytotherapy Research. 37(10). 4442–4456. 17 indexed citations
5.
Rangsinth, Panthakarn, et al.. (2023). A Review on the Sources, Structures, and Pharmacological Activities of Lucidenic Acids. Molecules. 28(4). 1756–1756. 23 indexed citations
6.
Li, Renkai, Panthakarn Rangsinth, Yiu Wa Kwan, et al.. (2023). Garcinone E triggers apoptosis and cell cycle arrest in human colorectal cancer cells by mediating a reactive oxygen species–dependent JNK signaling pathway. Biomedicine & Pharmacotherapy. 162. 114617–114617. 10 indexed citations
7.
Rangsinth, Panthakarn, et al.. (2023). Anti-inflammatory effect of gallic acid on HaCaT keratinocytes through the inhibition of MAPK-, NF-kB-, and Akt-dependent signaling pathways. Bangladesh Journal of Pharmacology. 18(1). 24–32. 1 indexed citations
8.
Cheng, Yanfen, Xuemei Zhong, Huan Gu, et al.. (2023). Glycyrrhetinic acid suppresses breast cancer metastasis by inhibiting M2-like macrophage polarization via activating JNK1/2 signaling. Phytomedicine. 114. 154757–154757. 42 indexed citations
9.
Li, Jingjing, Xin Nie, Panthakarn Rangsinth, et al.. (2023). Structure and activity relationship analysis of xanthones from mangosteen: Identifying garcinone E as a potent dual EGFR and VEGFR2 inhibitor. Phytomedicine. 122. 155140–155140. 4 indexed citations
10.
11.
Li, Jingjing, Renkai Li, Xiaoping Wu, et al.. (2022). An Update on the Potential Application of Herbal Medicine in Promoting Angiogenesis. Frontiers in Pharmacology. 13. 928817–928817. 22 indexed citations
12.
Wu, Xiaoping, Renkai Li, Jinming Zhang, et al.. (2021). The new andrographolide derivative AGS-30 induces apoptosis in human colon cancer cells by activating a ROS-dependent JNK signalling pathway. Phytomedicine. 94. 153824–153824. 22 indexed citations
13.
Li, Jingjing, Renkai Li, Xiaoping Wu, et al.. (2021). Amauroderma rugosum Protects PC12 Cells against 6‐OHDA‐Induced Neurotoxicity through Antioxidant and Antiapoptotic Effects. Oxidative Medicine and Cellular Longevity. 2021(1). 6683270–6683270. 14 indexed citations
14.
Li, Jingjing, et al.. (2021). Relaxation effect of narirutin on rat mesenteric arteries via nitric oxide release and activation of voltage-gated potassium channels. European Journal of Pharmacology. 905. 174190–174190. 7 indexed citations
15.
16.
Li, Jingjing, Fan Tang, Renkai Li, et al.. (2019). Dietary compound glycyrrhetinic acid suppresses tumor angiogenesis and growth by modulating antiangiogenic and proapoptotic pathways in vitro and in vivo. The Journal of Nutritional Biochemistry. 77. 108268–108268. 30 indexed citations
17.
Li, Jingjing, Feng Li, Fan Tang, et al.. (2019). AGS-30, an andrographolide derivative, suppresses tumor angiogenesis and growth in vitro and in vivo. Biochemical Pharmacology. 171. 113694–113694. 27 indexed citations
18.
Li, Renkai, Gph Leung, Song‐Lin Li, et al.. (2019). Application of UPLC‐MS/MS to simultaneously detect four bioactive compounds in the tumour‐shrinking decoction (FM1523) for uterine fibroids treatment. Phytochemical Analysis. 30(4). 447–455. 8 indexed citations
19.
Li, Renkai, et al.. (2000). In Vitro Activities of Voriconazole, Itraconazole, and Amphotericin B against Blastomyces dermatitidis , Coccidioides immitis , and Histoplasma capsulatum. Antimicrobial Agents and Chemotherapy. 44(6). 1734–1736. 147 indexed citations
20.
Warnock, David W., Beth A. Arthington‐Skaggs, & Renkai Li. (1999). Antifungal drug susceptibility testing and resistance in Aspergillus. Drug Resistance Updates. 2(5). 326–334. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nessim Kichik Breakdown of academic impact, for papers by Jundong Zhang Breakdown of academic impact, for papers by Jyh‐Sheng You Breakdown of academic impact, for papers by Caio César de Souza Alves Breakdown of academic impact, for papers by Lian‐Qiu Wu Breakdown of academic impact, for papers by Jongseok Lee Breakdown of academic impact, for papers by Anna H.Y. Law Breakdown of academic impact, for papers by Jinghua Yu
Rankless by CCL
2026